Convergent Bio Revenue
Nanotechnology Research • 
Minneapolis-St.Paul, United States • 1-10 Employees
$
Convergent Bio revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Nanotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Convergent Bio
Diwa Ratnam
Co-Founder
Company overview
| Headquarters | Minneapolis-St.Paul, United States |
| Website | |
| NAICS | 541713 |
| Employees | 1-10 |
| Socials |
About Convergent Bio
Our natural bioscience and technology breakthroughs solve the world’s greatest food supply challenges while ensuring the health of people and planet.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Convergent Bio has 1 employees across 1 departments.
Departments
Number of employees
Convergent Bio Tech Stack
Discover the technologies and tools that power Convergent Bio's digital infrastructure, from frameworks to analytics platforms.
Hosting
CMS
Miscellaneous
Security
JavaScript frameworks
JavaScript frameworks
Miscellaneous
Australia
Ireland
United Kingdom
South Africa
IndiaFrequently asked questions
Convergent Bio is located in Minneapolis-St.Paul, US.
Convergent Bio generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
Convergent Bio has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Convergent Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
